Show record details
This is a
Perma.cc
record
Captured
March 6, 2022 8:31 pm
March 6, 2022 8:31 p.m.
View
Mode
:
Standard
Screenshot
View the live page
What is Perma.cc?
Source page URL
Title
In reversal, FDA approves Duchenne muscular dystrophy drug
Description
The US Food and Drug Administration approved a Sarepta drug to treat Duchenne muscular dystrophy that it had rejected in April as ineffective.
Flag
as inappropriate